Health
Sanofi to start human trials of its second Covid vaccine candidate | – Macau Business
International, MNA | French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the…
French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the testing phase after having fallen behind in development.
Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.
The phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.
Phase 3 would be carried out on many more patients to determine its effectiveness.
…
-
General16 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News22 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General18 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News14 hours agoSerious traffic crash, Noosa – Sunshine Coast